Valuabl

Valuabl

Share this post

Valuabl
Valuabl
Krka, d. d. (WSE: KRK), valuation on April 27, 2022
Copy link
Facebook
Email
Notes
More
Investment ideas

Krka, d. d. (WSE: KRK), valuation on April 27, 2022

Apr 29, 2022
∙ Paid
2

Share this post

Valuabl
Valuabl
Krka, d. d. (WSE: KRK), valuation on April 27, 2022
Copy link
Facebook
Email
Notes
More
Share

Summary

  • Stock: Krka, d. d. (WSE: KRK) common equity

  • Market cap: €2.80bn

  • Rating: Buy

  • Price: €89.80

  • Target: €126.59

source: S&P Capital IQ

•••

Setting the stage

Krka, d. d., founded in 1954, is a Slovenian generic pharmaceutical manufacturer. The company makes money by developing, producing, marketing, and selling prescription and non-prescription generic drugs in…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 𝑉𝑎𝑙𝑢𝑎𝑏𝑙
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More